Prevention of "temporal hollowing" after fronto-orbital advancement for craniosynostosis.
J Craniofac Surg., Sep;5(4):271-4 (1994)
Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
J. Neurosurg., Dec;71(6):884-91 (1989)
Characterization of a protein product of human malignant glial tumors that induces microvascular permeability.
Adv Neurol., 52:469-74 (1990)
Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.
J. Neurosurg., Oct;83(4):682-9 (1995)
Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis.
J. Neurosurg., Oct;81(4):560-6 (1994)
Expression of angiogenic factors and structural proteins in central nervous system vascular malformations.
Neurosurgery., May;38(5):915-24; discussion 924-5 (1996)
Clinical neurosciences in the decade of the brain: hypotheses in neuro-oncology. VEG/PF acts upon the actin cytoskeleton and is inhibited by dexamethasone: relevance to tumor angiogenesis and vasogenic edema.
Yale J Biol Med., 69(4):337-55 (1996)
Intraventricular meningioma. A review of 10 cases of the National Hospital, Queen Square (1974-1985) with reference to the literature.
Acta Neurochir (Wien)., 83(3-4):83-91 (1986)
Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
J. Neurosurg., Dec;67(6):880-4 (1987)
Further characterization of malignant glioma-derived vascular permeability factor.
J. Neurosurg., Aug;69(2):254-62 (1988)
Measurement of intracranial tissue volume using computed tomographic images and a personal computer.
Neurosurgery., Nov;23(5):671-4 (1988)
Reversible acute and subacute myelopathy in patients with dural arteriovenous fistulas. Foix-Alajouanine syndrome reconsidered.
J. Neurosurg., Mar;70(3):354-9 (1989)